Medium materiality6/10
Oppenheimer Upgrades Transcat to Outperform
Why it may matterVerify against the original reporting
Bullish upgrade with material analyst-implied upside; the record provides no rationale for the change.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer upgraded TRNS to Outperform and set a $115 target versus the posted price of $89.52.
- Upgrade to Outperform is a clear positive rating change.
- The $115 target is about 28% above the posted price.
Key facts
- 01
Target: $115
- 02
Posted price: $89.52
- 03
Analyst firm: Oppenheimer
- 04
Analyst: Martin Yang
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.